INDIAGLYCO
India Glycols Limited (INDIAGLYCO) Stock Analysis
India Glycols Limited produces ethylene glycol, industrial chemicals, and natural gum products for plastics, packaging, and food. It combines petrochemical and renewable ingredient businesses. The company serves diverse downstream manufacturers. It is a listed specialty chemicals firm.
Basic Materials › Chemicals
₹309.80
-2.98% 1W | -70.50% 52W
Market Cap
2.1k CR
P/E Ratio
6.3
52W High
₹1222
52W Low
₹217
Div. Yield
2.44%
Beta
0.3
50 DMA
₹303.1
200 DMA
₹827.7
Profit Margin
7.4%
Inst. Own.
3.4%
📊 ANALYZING TREND
📉 CONSOLIDATING DOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 689 | 775 | 904 | 926 | 969 | 961 | 975 | 863 | 1,040 | 1,092 | 1,102 | 976 | 1,130 |
| YoY Sales growth | -15% | +16% | +63% | +50% | +41% | +24% | +8% | -7% | +7% | +14% | +13% | +13% | +9% |
| Expenses | 589 | 679 | 802 | 822 | 843 | 845 | 852 | 717 | 891 | 935 | 927 | 810 | 961 |
| Operating Profit | 100 | 96 | 102 | 105 | 126 | 116 | 124 | 146 | 150 | 158 | 175 | 166 | 170 |
| OPM % | 15% | 12% | 11% | 11% | 13% | 12% | 13% | 17% | 14% | 14% | 16% | 17% | 15% |
| Other Income | 12 | 12 | 9 | 10 | 14 | 15 | 19 | 13 | 20 | 14 | 3 | 14 | 21 |
| Interest | 28 | 29 | 31 | 33 | 36 | 40 | 44 | 45 | 45 | 49 | 47 | 26 | 25 |
| Depreciation | 21 | 28 | 26 | 26 | 28 | 28 | 27 | 33 | 34 | 38 | 41 | 41 | 42 |
| Profit before tax | 64 | 50 | 54 | 56 | 76 | 63 | 71 | 82 | 91 | 84 | 91 | 112 | 123 |
| Tax % | 20% | 24% | 23% | 24% | 20% | 22% | 20% | 22% | 19% | 22% | 25% | 23% | 21% |
| Net Profit | 51 | 38 | 42 | 42 | 60 | 50 | 57 | 64 | 73 | 65 | 68 | 87 | 97 |
| EPS in Rs | 8.25 | 6.13 | 6.71 | 6.81 | 9.74 | 8.02 | 9.16 | 10.33 | 11.81 | 10.51 | 10.09 | 12.97 | 14.45 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,579 | 2,324 | 2,500 | 3,034 | 3,357 | 2,735 | 2,317 | 2,868 | 2,651 | 3,294 | 3,768 | 4,211 | 4,301 |
| Sales growth | -13% | -10% | +8% | +21% | +11% | -19% | -15% | +24% | -8% | +24% | +14% | +12% | +12% |
| Expenses | 2,455 | 2,149 | 2,263 | 2,712 | 2,941 | 2,433 | 2,026 | 2,599 | 2,346 | 2,879 | 3,257 | 3,562 | 3,632 |
| Operating Profit | 124 | 175 | 237 | 322 | 416 | 303 | 291 | 269 | 305 | 415 | 511 | 649 | 669 |
| OPM % | 4.8% | 8% | 9% | 11% | 12% | 11% | 13% | 9% | 12% | 13% | 14% | 15% | 16% |
| Other Income | -16 | -47 | 7 | 23 | 17 | 24 | 15 | 260 | 54 | 30 | 61 | 50 | 51 |
| Interest | 163 | 139 | 127 | 125 | 143 | 97 | 83 | 70 | 100 | 121 | 164 | 167 | 148 |
| Depreciation | 89 | 69 | 72 | 73 | 76 | 78 | 80 | 80 | 94 | 101 | 115 | 155 | 163 |
| Profit before tax | -144 | -81 | 45 | 147 | 213 | 153 | 143 | 379 | 165 | 223 | 292 | 377 | 410 |
| Tax % | -38% | -30% | 22% | 34% | 38% | 25% | 8% | 10% | 15% | 23% | 21% | 22% | |
| Net Profit | -89 | -57 | 35 | 97 | 133 | 115 | 132 | 340 | 141 | 173 | 231 | 293 | 316 |
| EPS in Rs | -14.30 | -9.16 | 5.65 | 15.57 | 21.39 | 18.49 | 21.23 | 54.81 | 20.17 | 27.90 | 37.25 | 43.70 | 48.02 |
| Dividend Payout % | 0% | 0% | 9% | 13% | 14% | 16% | 14% | 7% | 19% | 14% | 13% | 17% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 17.0% | 13.0% | 6.0% |
| Profit CAGR | 39.0% | 14.0% | 74.0% |
Shareholding Pattern
Promoters61.02%
FIIs2.62%
DIIs1.34%
Public35.04%
Promoters59.63%
FIIs2.42%
DIIs5.22%
Public32.72%
Promoters59.63%
FIIs2.27%
DIIs5.19%
Public32.91%
Promoters59.63%
FIIs2.24%
DIIs5.21%
Public32.91%
Promoters59.63%
FIIs2.77%
DIIs3.06%
Public34.54%
Promoters61.02%
FIIs1.17%
DIIs4.17%
Public33.64%
Promoters61.02%
FIIs1.80%
DIIs0.08%
Public37.11%
Promoters61.02%
FIIs2.24%
DIIs0.91%
Public35.82%
Promoters59.63%
FIIs2.27%
DIIs5.19%
Public32.91%
Promoters59.63%
FIIs2.77%
DIIs3.06%
Public34.54%
INDIAGLYCO
Holdings Analysis
Key strengths & risk signals
69
Overall
77
Fundamental
62
Technical
Risks (4)
LOW MARGIN! 7.4% profit margin - thin profits.
POOR YEAR! Stock declined 70.5% in the last year.
WEAK! Trading at 9.2% of 52W range - near yearly lows.
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.0% (1 week), 12.1% (1 month), 70.8% (3 months).
Strengths (4)
UNDERVALUED! PEG of 0.19 indicates stock is cheap relative to growth.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 2,777,456 vs down days: 822,409. Ratio: 3.38x
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 38.3 - watch for reversal.
Fundamental & Technical Analysis
69Overall
77Fundamental
62Technical
Fundamental Breakdown
Growth Quality
28/30
Revenue CAGR: 17.3% (VERY GOOD, 13/15). Profit CAGR: 32.8% (EXCELLENT, 15/15).
Profit Margin
3/10
LOW MARGIN! 7.4% profit margin - thin profits.
PEG Valuation
10/10
UNDERVALUED! PEG of 0.19 indicates stock is cheap relative to growth.
Dividend Yield
6/10
MODERATE DIVIDEND! 2.44% yield - some income benefit.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 35.86% public ownership - moderate retail influence.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (303.1) is below 200-day average (827.7) - negative signal.
Price Position
6/10
MIXED POSITION! Current price (309.8) above 50-day but below 200-day.
Trend Pattern
10/20
Current trend: CONSOLIDATING DOWN
52W Performance
0/10
POOR YEAR! Stock declined 70.5% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 2,777,456 vs down days: 822,409. Ratio: 3.38x
RSI
4/5
APPROACHING OVERSOLD! RSI at 38.3 - watch for reversal.
52W Range
1/5
WEAK! Trading at 9.2% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.0% (1 week), 12.1% (1 month), 70.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
INDIAGLYCO
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-22 | Concall PDF | |
| Q3FY262026-02-17 | Concall PDF | |
| Q2FY262025-11-21 | Concall PDF |
Peer Comparison
Basic Materials · Chemicals · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INDIAGLYCO | ₹309.80 | 6.3 | 7.4% | 17.3% | 32.8% | -70.5% | 69 | CONSOLIDATING DOWN | +32.2% | +11.4% | +8.6% | +15.8% |
| SANSTAR | ₹99.20 | 41.3 | 5.4% | -13.8% | -6.2% | +2.3% | 52 | CONSOLIDATING DOWN | -3,166.7% | -55.1% | +21.5% | -4.9% |
| IGPL | ₹581.70 | 21.9 | 7.1% | 11.0% | -59.0% | +49.7% | 68 | APPROACHING RESISTANCE | -4,350.0% | +28.0% | +63.1% | +22.9% |
| DCW | ₹47.30 | 20.6 | 2.9% | -6.8% | -36.9% | -31.1% | 53 | BREAKOUT | -24.6% | -69.9% | +22.9% | +22.3% |
| BEPL | ₹112.20 | 12.6 | 14.6% | -2.2% | 9.6% | +15.1% | 52 | BREAKDOWN | – | -4.7% | – | -14.6% |
| UNIENTER | ₹96.80 | 34.1 | 77.5% | 179.1% | -19.2% | -39.3% | 63 | BREAKOUT | +71.4% | +71.4% | -100.0% | -100.0% |
| GODAVARIB | ₹226.10 | 7536.3 | 1.2% | 5.0% | 4.0% | -13.6% | 54 | BOUNCE FROM SUPPORT | -63.9% | -22.3% | +27.4% | -1.6% |
| INDOBORAX | ₹385.20 | 21.9 | 23.3% | 8.0% | 1.0% | +42.3% | 62 | BREAKDOWN | -70.9% | -70.9% | +2.0% | -16.3% |
Data from TradeAlone · Updated daily
INDIAGLYCO News
India Glycols Limited (indiaglyco) Unveils Investor Presentation on Ennature Biopharma’s Growth Strategy2026-09-02India Glycols Limited (indiaglyco) Q1fy27: Strong Start with Double-digit Growth2026-08-14India Glycols Limited (INDIAGLYCO) pulls back from breakout highs, falls 5%2026-08-10India Glycols Limited (NSE: INDIAGLYCO) breaks out, moves up 5% intraday2026-07-15India Glycols Limited (indiaglyco) Q4 & FY26 Investor Presentation: Strong Financial Performance2026-05-18
